Publications by authors named "Elisa Cops"

Claim this Profile
U
Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres.
Cristina Fortuno, Elisa J Cops, Aimee L Davidson, Johanna Hadler, Giovanni Innella

Eur J Hum Genet· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Risks Associated With Pathogenic Variants: Maximum Likelihood Analysis of Extended Pedigrees for Diagnosis of First Cancers Beyond the Li-Fraumeni Syndrome Spectrum.
Cristina Fortuno, Bing-Jian Feng, Courtney Carroll, Giovanni Innella, Wendy Kohlmann, Elisa Cops

JCO Precis Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical utility and costs of whole-genome sequencing to detect cancer susceptibility variants-a multi-site prospective cohort study.
Aimee L Davidson, Uwe Dressel, Sarah Norris, Daffodil M Canson, Dylan M Glubb, Elisa J Cops

Genome Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the impact of the reclassification of a hereditary cancer syndrome gene variant: emerging themes from a qualitative study.
Laura Wedd, Margaret Gleeson, Bettina Meiser, Rosie O'Shea, Kristine Barlow-Stewart, Elisa Cops

J Community Genet· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stakeholder attitudes towards establishing a national genomics registry of inherited cancer predisposition: a qualitative study.
Bettina Meiser, Melissa Monnik, Rachel Austin, Cassandra Nichols, Elisa Cops

J Community Genet· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice.
Bettina Meiser, Rajneesh Kaur, April Morrow, Michelle Peate, W K Tim Wong, Elisa Cops

Hered Cancer Clin Pract· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.
Michael T Parsons, Emma Tudini, Hongyan Li, Eric Hahnen, Barbara Wappenschmidt, Elisa J Cops

Hum Mutat· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations of the Sonic Hedgehog Pathway Underlie Hypothalamic Hamartoma with Gelastic Epilepsy.
Michael S Hildebrand, Nicole G Griffin, John A Damiano, Elisa J Cops, Rosemary Burgess

Am J Hum Genet· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue-type plasminogen activator is an extracellular mediator of Purkinje cell damage and altered gait.
Elisa J Cops, Maithili Sashindranath, Maria Daglas, Kieran M Short, Candida da Fonseca Pereira

Exp Neurol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans.
Maithili Sashindranath, Eunice Sales, Maria Daglas, Roxann Freeman, Andre L Samson, Elisa J Cops

Brain· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleocytoplasmic coagulation: an injury-induced aggregation event that disulfide crosslinks proteins and facilitates their removal by plasmin.
Andre L Samson, Anja S Knaupp, Maithili Sashindranath, Rachael J Borg, Amanda E-L Au, Elisa J Cops

Cell Rep· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors.
Elisa J Cops, Tina Bianco-Miotto, Nicole L Moore, Christine L Clarke, Stephen N Birrell

J Steroid Biochem Mol Biol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate.
Grant Buchanan, Stephen N Birrell, Amelia A Peters, Tina Bianco-Miotto, Katrina Ramsay, Elisa J Cops

Cancer Res· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis